1119 related articles for article (PubMed ID: 26230475)
1. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
[TBL] [Abstract][Full Text] [Related]
2. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
Lan F; Qing Q; Pan Q; Hu M; Yu H; Yue X
Cell Oncol (Dordr); 2018 Feb; 41(1):25-33. PubMed ID: 29076027
[TBL] [Abstract][Full Text] [Related]
3. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
Lai NS; Dong QS; Ding H; Miao ZL; Lin YC
J Clin Neurosci; 2014 May; 21(5):755-60. PubMed ID: 24382515
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma.
Guan Y; Chen L; Bao Y; Pang C; Cui R; Li G; Liu J; Wang Y
Int J Clin Exp Pathol; 2015; 8(1):727-34. PubMed ID: 25755767
[TBL] [Abstract][Full Text] [Related]
6. Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma.
Lai NS; Wu DG; Fang XG; Lin YC; Chen SS; Li ZB; Xu SS
Br J Cancer; 2015 Mar; 112(7):1241-6. PubMed ID: 25756397
[TBL] [Abstract][Full Text] [Related]
7. Potential Diagnostic and Prognostic Value of Plasma Circulating MicroRNA-182 in Human Glioma.
Xiao Y; Zhang L; Song Z; Guo C; Zhu J; Li Z; Zhu S
Med Sci Monit; 2016 Mar; 22():855-62. PubMed ID: 26978735
[TBL] [Abstract][Full Text] [Related]
8. Concomitant microRNA-31 downregulation and radixin upregulation predicts advanced tumor progression and unfavorable prognosis in patients with gliomas.
Wang S; Jiao B; Geng S; Song J; Liang Z; Lu S
J Neurol Sci; 2014 Mar; 338(1-2):71-6. PubMed ID: 24380686
[TBL] [Abstract][Full Text] [Related]
9. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas.
Yang C; Wang C; Chen X; Chen S; Zhang Y; Zhi F; Wang J; Li L; Zhou X; Li N; Pan H; Zhang J; Zen K; Zhang CY; Zhang C
Int J Cancer; 2013 Jan; 132(1):116-27. PubMed ID: 22674182
[TBL] [Abstract][Full Text] [Related]
10. Plasma miR-185 as a predictive biomarker for prognosis of malignant glioma.
Tang H; Liu Q; Liu X; Ye F; Xie X; Xie X; Wu M
J Cancer Res Ther; 2015; 11(3):630-4. PubMed ID: 26458593
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the Diagnostic Utility of Serum MicroRNA Classification in Patients With Diffuse Glioma.
Ohno M; Matsuzaki J; Kawauchi J; Aoki Y; Miura J; Takizawa S; Kato K; Sakamoto H; Matsushita Y; Takahashi M; Miyakita Y; Ichimura K; Narita Y; Ochiya T
JAMA Netw Open; 2019 Dec; 2(12):e1916953. PubMed ID: 31808923
[TBL] [Abstract][Full Text] [Related]
12. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
[TBL] [Abstract][Full Text] [Related]
13. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.
Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C
Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of plasma miR-124 expression is a predictive biomarker for prognosis of glioma.
Wang LQ; Sun W; Wang Y; Li D; Hu AM
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):271-276. PubMed ID: 30657585
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
[TBL] [Abstract][Full Text] [Related]
17. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.
Shi R; Wang PY; Li XY; Chen JX; Li Y; Zhang XZ; Zhang CG; Jiang T; Li WB; Ding W; Cheng SJ
Oncotarget; 2015 Sep; 6(29):26971-81. PubMed ID: 26284486
[TBL] [Abstract][Full Text] [Related]
18. A novel serum microRNA-based identification and classification biomarker of human glioma.
Xing W; Zeng C
Tumour Biol; 2017 May; 39(5):1010428317705339. PubMed ID: 28475008
[TBL] [Abstract][Full Text] [Related]
19. Decreased Expression of miR-15b in Human Gliomas is Associated with Poor Prognosis.
Sun G; Yan S; Shi L; Wan Z; Jiang N; Li M; Guo J
Cancer Biother Radiopharm; 2015 May; 30(4):169-73. PubMed ID: 25811315
[TBL] [Abstract][Full Text] [Related]
20. Identification of microRNA-205 as a potential prognostic indicator for human glioma.
Hou SX; Ding BJ; Li HZ; Wang L; Xia F; Du F; Liu LJ; Liu YH; Liu XD; Jia JF; Li L; Wu ZL; Zhao G; Zhang ZG; Deng YC
J Clin Neurosci; 2013 Jul; 20(7):933-7. PubMed ID: 23683741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
